The FDA recently expanded the approval of the XHANCE fluticasone propionate nasal spray manufactured by Optinose for chronic rhinosinusitis to also include treatment of adults aged 18 and older without nasal polyps.

The FDA recently expanded the approval of the XHANCE fluticasone propionate nasal spray manufactured by Optinose for chronic rhinosinusitis to also include treatment of adults aged 18 and older without nasal polyps.
Unconscious associations between certain scents can affect how we perceive certain colors.
The aim of oroantral fistula management is to repair the defect, restoring the integrity of the sinus and oral cavity and preventing sinus infections.
Nasodine, an over-the-counter preparation, shows effective antibiofilm agent that is highly active against biofilms and holds promise for the management of sinonasal biofilms in CRS.
The combination of lexacaftor/tezacaftor/ivacaftor has been shown to have positive effects on multiple organ systems.
Gustatory function findings show that significant association existed between overall COVID-19 symptom severity and smell or taste loss, as well as failure to regain full sensory function
YouTube, recently cited as the most used video forum for surgical preparation among residents and medical students, suggests videos to users based on an algorithm that prioritizes video metrics over quality.
Local nasal immunotherapy is a safe alternative immunotherapy route that improves clinical symptoms, reduces medication usage, and increases the nasal provocation threshold.
Should transoral options be limited or unavailable, recent reports have demonstrated success in closing oroantral fistulae with different intranasal mucosal flaps.
Although the number of randomized control trials is lacking, the current literature suggests mucosal flap preservation may improve outcomes following endoscopic dacryocystorhinostomy.